Deutsche Bank
GTHX

Deutsche Bank’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Deutsche Bank’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-24,030
Closed -$183K – 4372
2022
Q1 		$183K Sell
24,030
-1,024
-4% -$9.71K ﹤0.01% 3321
2021
Q4 		$255K Buy
25,054
+1,877
+8% +$23.9K ﹤0.01% 3254
2021
Q3 		$311K Sell
23,177
-729
-3% -$11.9K ﹤0.01% 3322
2021
Q2 		$525K Sell
23,906
-1,593
-6% -$35.4K ﹤0.01% 3191
2021
Q1 		$614K Sell
25,499
-7,873
-24% -$183K ﹤0.01% 2972
2020
Q4 		$600K Buy
33,372
+12,235
+58% +$183K ﹤0.01% 2781
2020
Q3 		$245K Sell
21,137
-39,805
-65% -$657K ﹤0.01% 3112
2020
Q2 		$1.48M Sell
60,942
-373,059
-86% -$6.17M ﹤0.01% 1981
2020
Q1 		$4.78M Buy
434,001
+420,834
+3,196% +$7.86M ﹤0.01% 1273
2019
Q4 		$347K Buy
13,167
+2,768
+27% +$64.7K ﹤0.01% 2916
2019
Q3 		$236K Sell
10,399
-3,377
-25% -$106K ﹤0.01% 3090
2019
Q2 		$421K Sell
13,776
-168,459
-92% -$3.55M ﹤0.01% 3389
2019
Q1 		$3.02M Buy
182,235
+134,618
+283% +$2.55M ﹤0.01% 2195
2018
Q4 		$911K Sell
47,617
-29,151
-38% -$1.09M ﹤0.01% 2958
2018
Q3 		$4.01M Buy
76,768
+27,665
+56% +$1.51M ﹤0.01% 2370
2018
Q2 		$2.13M Buy
49,103
+13,755
+39% +$589K ﹤0.01% 2906
2018
Q1 		$1.31M Buy
35,348
+16,140
+84% +$431K ﹤0.01% 3150
2017
Q4 		$380K Buy
19,208
+12,136
+172% +$261K ﹤0.01% 3741
2017
Q3 		$175K Buy
+7,072
New +$131K ﹤0.01% 3945

Other funds holding GTHX

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deutsche Bank's GTHX Position: Q2 2022 in Review

Deutsche Bank sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q2 2022, closing a stake of 24,030 shares — an estimated $183K sold.

Deutsche Bank first reported a position in GTHX in Q3 2017 and held it in 19 quarters. The position peaked at $4.78M in Q1 2020. 98 funds tracked by Wall St. Rank hold GTHX as of Q2 2022.

  • Deutsche Bank reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Deutsche Bank sold 24,030 G1 Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $183K.
  • Deutsche Bank first reported a position in G1 Therapeutics, Inc. Common Stock in Q3 2017 and held it in 19 quarters.
  • Deutsche Bank's G1 Therapeutics, Inc. Common Stock position peaked at $4.78M in Q1 2020.
  • 98 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q2 2022.

Based on Deutsche Bank's 13F filing for Q2 2022, filed 11 Aug 2022.